Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1861 participants.
Also called NCT05540223
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,861 participants
- Sponsor
- Registry
-
NCT05540223
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05540223. Randomized; no masking; primary purpose treatment. Start 2024-05-13 (actual); primary completion 2027-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System
- Acronym
- BIOMAG-II
- Condition
- Coronary Artery Disease
- Condition
- Atherosclerosis, Coronary
- Condition
- Myocardial Ischemia
- Condition
- Ischemic Heart Disease
- Condition
- Acute Coronary Syndrome
- Condition
- Angina Pectoris
- Intervention (Device)
- Freesolve RMS
- Intervention (Device)
- Xience DES
- Lead sponsor
- Biotronik AG
Record details
- Record id
cardio:ct-nct05540223- Content hash
1ab827d118c4829ab5176e6bf8ca707479b954f1d25d4e33a7150f42161c3a7c